Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2022-03-09 00:00:00 ET · period of report 2022-03-07 · accession 0001104659-22-032022 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-09 | 2022-03-07 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas | M - OptEx | $13.35 | +13.0K | 119.1K | +12% | +$173.9K |
| D | 2022-03-09 | 2022-03-07 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas | S - Sale+OE | $29.35 | -13.0K | 106.0K | -11% | -$382.3K |
| D | 2022-03-09 | 2022-03-07 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas | M - OptEx | $0.00 | -13.0K | 59.5K | -18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-07 | M | A | 13,026 | $13.35 | 119,068 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-07 | S | D | 13,026 | $29.35 | 106,042 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2022-03-07 | M | D | 13,026 | $0.00 | 59,522 | D | $13.35 · — to 2027-03-16 | 13,026 Common Stock | (F2) Shares subject to the option are fully vested and immediately exercisable. |